Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers

For many years, luteinizing hormone-releasing hormone or gonadotropin-releasing hormone (GnRH) analogs have been used to treat androgen or estrogen-dependent tumors. However, emerging evidence shows that the GnRH receptor (GnRH-R) is overexpressed in several cancer cells, including ovarian, endometr...

Full description

Bibliographic Details
Main Authors: Maritza P. Garrido, Andrea Hernandez, Margarita Vega, Eyleen Araya, Carmen Romero
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
GnRH
targeted therapy
ovarian cancer
breast cancer
prostatic cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1143261/full

Similar Items

Similar Items